Shingles News

Researchers found people 50 and older who had COVID were 15% more likely to develop shingles, compared to people who were never infected.

Pfizer and BioNTech plan to develop a vaccine for shingles using the same mRNA technology that made the companies’ COVID-19 vaccine.

A panel of CDC advisors has voted to recommend the shingles vaccine Shingrix for people with immune system deficiencies who are age 19 or or older.

Overall stroke risk dropped 20% among patients under age 80 who got the shingles vaccine. In patients 80 and older, risk was cut by about 10%, said researchers.

The new vaccine is more than 90% effective at preventing shingles and a painful complication called postherpetic neuralgia (PHN) in all age groups.

Kids who were vaccinated against chickenpox had a 78% lower risk of developing shingles, the researchers said.

More doses of Shingrix, the shingles vaccine that has been in very short supply, are on the way to U.S. pharmacies, says drugmaker GlaxoSmithKline. However, demand may still outpace supply.

For months, demand for Shingrix, the shingles vaccine approved by the FDA in October 2017, has outpaced supply, frustrating patients and providers alike.

Over the last six decades, there has been a steady uptick in the number of shingles cases in the United States -- even among younger adults. What's behind it? Researchers have a few theories.

Supplies of a new and more effective shingles vaccine are running low in the United States.

New vaccine, said to be more effective, is second approved for U.S. market.

More research is needed, but doctors should warn patients, researchers say

Found to protect about 90 percent of adults age 70 and up

Chance of stroke, heart attack increased most in the first week after diagnosis of the painful rash

Findings support immunization of older adults

The live-virus shingles vaccine may be safe for people with autoimmune conditions and for those taking immunity-suppressing drugs.

A new study offers up some encouraging news for people who have recently experienced a painful bout of shingles.

The FDA has approved a drug currently used for restless leg syndrome to treat a common and painful complication of shingles, according to the medication's manufacturers.

The shingles vaccine is “generally safe and well tolerated,” according to a study of nearly 200,000 patients.

The FDA today approved Merck's Zostavax shingles vaccine for 50-somethings. The vaccine was already approved for people age 60 and older.

The herpes zoster vaccine, better known as the shingles vaccine and recommended for adults 60-plus, cuts the risk of getting the painful disease by 55%, new research finds.

The FDA has approved Qutenza for post-herpetic neuralgia (PHN), lingering nerve pain after a shingles attack. The doctor-applied patches deliver synthetic capsaicin, the chemical that makes chili peppers hot.

People with shingles are more likely to suffer a recurrence than previously thought, especially if their attack is accompanied by lasting pain, researchers report.

Adults with shingles are at increased risk for stroke, especially if they have shingles that affects the eyes, a study shows.

A surgically implanted pump that delivers medication to the spinal fluid helps reduce the persistent pain that can linger in some patients after they recover from shingles, according to a new study.